Eptinezumab in treatment-resistant chronic migraine: Four-year real-world effectiveness and treatment persistence.
Saved in:
| Title: | Eptinezumab in treatment-resistant chronic migraine: Four-year real-world effectiveness and treatment persistence. |
|---|---|
| Authors: | Hsieh WJ; Department of Neurology, Thomas Jefferson University, Philadelphia, PA, USA., Nicol K; Department of Neurology, Thomas Jefferson University, Philadelphia, PA, USA., Ng CC; Department of Neurology, Thomas Jefferson University, Philadelphia, PA, USA., Hou TW; Department of Neurology, Thomas Jefferson University, Philadelphia, PA, USA., Phan P; Department of Neurology, Thomas Jefferson University, Philadelphia, PA, USA., Keith SW; Division of Biostatistics & Bioinformatics, Thomas Jefferson University, Philadelphia, PA, USA., Heckel B; Department of Neurology, Thomas Jefferson University, Philadelphia, PA, USA., Marmura MJ; Department of Neurology, Thomas Jefferson University, Philadelphia, PA, USA., Yuan H; Department of Neurology, Thomas Jefferson University, Philadelphia, PA, USA. |
| Source: | Cephalalgia : an international journal of headache [Cephalalgia] 2026 May; Vol. 46 (5), pp. 3331024261451427. Date of Electronic Publication: 2026 May 19. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Country of Publication: England NLM ID: 8200710 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-2982 (Electronic) Linking ISSN: 03331024 NLM ISO Abbreviation: Cephalalgia Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1468-2982 |
|---|---|
| DOI: | 10.1177/03331024261451427 |
